Global Injectable Drug Delivery Market Outlook 2017-2026: Market to Grow from $404 Billion in 2017 to Reach $1199 Billion by 2026 - ResearchAndMarkets.com
Aug. 28, 2018
DUBLIN--(BUSINESS WIRE)--Aug 28, 2018--The "Injectable Drug Delivery - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
According to the Global Injectable Drug Delivery market is expected to grow from $404.14 billion in 2017 to reach $1199.89 billion by 2026 with a CAGR of 12.8%.
Increasing prevalence of chronic diseases, expansion in the biologics market and technological advances in the form of nanotechnologies are some of the factors propelling the market growth. However, growing injuries and the infections caused by needles are hampering the market growth.
Based on formulation packaging, Ampules segment has a significant growth in the market owing to its good barrier properties as compared to other types of packaging. In addition, better protection at a lesser cost, ease of transportation and low costs of manufacturing are the factors driving the market in this segment.
By Geography, North America was estimated to be the largest share for the market during the forecast period. The growth is attributed to the rising dominance of chronic diseases and the number of companies that are focused on collaboration and partnerships to ensure the availability of high-value products.
Key Topics Covered:
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Injectable Drug Delivery Market, By Type
6 Global Injectable Drug Delivery Market, By Formulation Packaging
7 Global Injectable Drug Delivery Market, By Usage Pattern
8 Global Injectable Drug Delivery Market, By Facility of Use
9 Global Injectable Drug Delivery Market, By Site of Administration
10 Global Injectable Drug Delivery Market, By Application
11 Global Injectable Drug Delivery Market, By Distribution Channel
12 Global Injectable Drug Delivery Market, By End User
13 Global Injectable Drug Delivery Market, By Geography
14 Key Developments
15 Company ProfilingBaxter International, Inc. ELI Lilly and Company Terumo Corporation Becton, Dickinson and Company Pfizer, Inc. Gerresheimer AG Teva Pharmaceutical Industries Ltd. Schott AG Sandoz Antares Pharma, Inc. Zogenix, Inc. Scandinavian Health Limited Terumo Medical Corp. Ypsomed Holding AG Unilife Corporation, Vetter Pharma-Fertigung GmbH & Co. KG. Nova Nordisk A/S
For more information about this report visit https://www.researchandmarkets.com/research/n2mgfg/global_injectable?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180828005648/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infusions and Injectables
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/28/2018 12:48 PM/DISC: 08/28/2018 12:48 PM